InvestorsHub Logo
Followers 3
Posts 531
Boards Moderated 0
Alias Born 01/13/2013

Re: ignatiusrielly35 post# 33533

Wednesday, 09/13/2017 11:07:42 AM

Wednesday, September 13, 2017 11:07:42 AM

Post# of 108192
Iggy,
What is vague about this ?

"As part of its portfolio refinement, the company has determined it will not pursue further clinical study of ADXS-HER2 at this time, but remains open to ISTs or licensing opportunities."

That seems pretty clear, no?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News